KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Cash (2017 - 2025)

Historic Change in Cash for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to -$34.4 million.

  • Twist Bioscience's Change in Cash fell 57888.82% to -$34.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$73.1 million, marking a year-over-year decrease of 6218.12%. This contributed to the annual value of -$43.7 million for FY2025, which is 2733.55% up from last year.
  • Twist Bioscience's Change in Cash amounted to -$34.4 million in Q4 2025, which was down 57888.82% from -$18.5 million recorded in Q3 2025.
  • Twist Bioscience's 5-year Change in Cash high stood at $216.0 million for Q1 2022, and its period low was -$274.2 million during Q4 2021.
  • Over the past 5 years, Twist Bioscience's median Change in Cash value was -$10.3 million (recorded in 2021), while the average stood at -$10.0 million.
  • Per our database at Business Quant, Twist Bioscience's Change in Cash surged by 32739.02% in 2022 and then crashed by 139673.2% in 2024.
  • Quarter analysis of 5 years shows Twist Bioscience's Change in Cash stood at -$274.2 million in 2021, then soared by 77.69% to -$61.2 million in 2022, then soared by 67.03% to -$20.2 million in 2023, then skyrocketed by 74.84% to -$5.1 million in 2024, then plummeted by 578.89% to -$34.4 million in 2025.
  • Its last three reported values are -$34.4 million in Q4 2025, -$18.5 million for Q3 2025, and -$9.0 million during Q2 2025.